Long-term Maintenance of Remission with No Dose Escalation After Re-induction with Certolizumab Pegol in Patients with Crohn's Disease Exacerbation Who Were Naive to Anti-TNF Treatment: 4-Year Results from the PRECiSE 4 Study

被引：1

作者：

Sandborn, William ^{[1
]}

Schreiber, Stefan ^{[2
]}

Hanauer, Stephen ^{[3
]}

Colombel, Jean-Frederic ^{[4
]}

Bloomfield, Ralph ^{[5
]}

Lichtenstein, Gary ^{[6
]}

机构：

[1] Mayo Clin, Rochester, MN USA

[2] Univ Kiel, Kiel, Germany

[3] Univ Chicago, Med Ctr, Chicago, IL 60637 USA

[4] Hop Claude Huriez, Lille, France

[5] UCB Pharma, Slough, Berks, England

[6] Univ Penn, Sch Med, Philadelphia, PA 19104 USA

来源：

AMERICAN JOURNAL OF GASTROENTEROLOGY | 2010年 / 105卷

关键词：

D O I：

10.14309/00000434-201010001-01153

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1153

引用

页码：S418 / S418

页数：1

共 31 条